Specificity profiling of human trypsin-isoenzymes

References

Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., and Bourne, P.E. (2000). The Protein Data Bank. Nucleic Acids Res. 28, 235–242.10.1093/nar/28.1.235Suche in Google Scholar

Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Gallo Cassarino, T., Bertoni, M., Bordoli, L., et al. (2014). SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252–W258.10.1093/nar/gku340Suche in Google Scholar

Biniossek, M.L., Niemer, M., Maksimchuk, K., Mayer, B., Fuchs, J., Huesgen, P.F., McCafferty, D.G., Turk, B., Fritz, G., Mayer, J., et al. (2016). Identification of protease specificity by combining proteome-derived peptide libraries and quantitative proteomics. Mol. Cell. Proteomics 15, 2515–2524.10.1074/mcp.O115.056671Suche in Google Scholar

Bläckberg, M., Berling, R., and Ohlsson, K. (1999). Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin. Pancreas 19, 325–334.10.1097/00006676-199911000-00002Suche in Google Scholar

Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., and Gevaert, K. (2009). Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786–787.10.1038/nmeth1109-786Suche in Google Scholar

Debela, M., Magdolen, V., Bode, W., Brandstetter, H., and Goettig, P. (2016). Structural basis for the Zn²⁺ inhibition of the zymogen-like kallikrein-related peptidase 10. Biol. Chem. 397, 1251–1264.10.1515/hsz-2016-0205Suche in Google Scholar

Figarella, C., Clemente, F., and Guy, O. (1969). On zymogens of human pancreatic juice. FEBS Lett. 3, 351–353.10.1016/0014-5793(69)80176-6Suche in Google Scholar

Fuhrman-Luck, R.A., Loessner, D., and Clements, J.A. (2014). Kallikrein-related peptidases in prostate cancer: from molecular function to clinical application. EJIFCC 25, 269–281.Suche in Google Scholar

Goyal, J., Smith, K.M., Cowan, J.M., Wazer, D.E., Lee, S.W., and Band, V. (1998). The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58, 4782–4786.Suche in Google Scholar

Hansson, L., Strömqvist, M., Bäckman, A., Wallbrandt, P., Carlstein, A., and Egelrud, T. (1994). Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J. Biol. Chem. 269, 19420–19426.10.1016/S0021-9258(17)32185-3Suche in Google Scholar

Harris, J.L., Backes, B.J., Leonetti, F., Mahrus, S., Ellman, J.A., and Craik, C.S. (2000). Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA 97, 7754–7759.10.1073/pnas.140132697Suche in Google Scholar PubMed PubMed Central

Hegyi, E. and Sahin-Tóth, M. (2017). Genetic risk in chronic pancreatitis: the trypsin-dependent pathway. Dig. Dis. Sci. 62, 1692–1701.10.1007/s10620-017-4601-3Suche in Google Scholar PubMed PubMed Central

Hirota, M., Ohmuraya, M., and Baba, H. (2006). The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis. J. Gastroenterol. 41, 832–836.10.1007/s00535-006-1874-2Suche in Google Scholar

Hockla, A., Radisky, D.C., and Radisky, E.S. (2010). Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109. Breast Cancer Res. Treat. 124, 27–38.10.1007/s10549-009-0699-0Suche in Google Scholar

Hockla, A., Miller, E., Salameh, M.A., Copland, J.A., Radisky, D.C., and Radisky, E.S. (2012). PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer. Mol. Cancer Res. 10, 1555–1566.10.1158/1541-7786.MCR-12-0314Suche in Google Scholar

Hu, J., Lei, H., Fei, X., Liang, S., Xu, H., Qin, D., Wang, Y., Wu, Y., and Li, B. (2015). NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells. Sci. Rep. 5, 17426.10.1038/srep17426Suche in Google Scholar

Jiang, G., Cao, F., Ren, G., Gao, D., Bhakta, V., Zhang, Y., Cao, H., Dong, Z., Zang, W., Zhang, S., et al. (2010). PRSS3 promotes tumour growth and metastasis of human pancreatic cancer. Gut 59, 1535–1544.10.1136/gut.2009.200105Suche in Google Scholar

Katona, G., Berglund, G.I., Hajdu, J., Graf, L., and Szilagyi, L. (2002). Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. J. Mol. Biol. 315, 1209–1218.10.1006/jmbi.2001.5305Suche in Google Scholar

Knecht, W., Cottrell, G.S., Amadesi, S., Mohlin, J., Skaregarde, A., Gedda, K., Peterson, A., Chapman, K., Hollenberg, M.D., Vergnolle, N., et al. (2007). Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia. J. Biol. Chem. 282, 26089–26100.10.1074/jbc.M703840200Suche in Google Scholar

Koistinen, H. and Stenman, U.-H. (2012). PSA (Prostate-Specific Antigen) and other Kallikrein-Related Peptidases in Prostate Cancer. In: Kallikrein-Related Peptidases Vol. 2 – Novel Cancer Related Biomarkers, V. Magdolen, C.P. Sommerhoff, H. Fritz and M. Schmitt, eds. (Berlin, Germany: De Gruyter), pp. 61–81.10.1515/9783110303667.61Suche in Google Scholar

Koistinen, H., Koistinen, R., Zhang, W.-M., Valmu, L., and Stenman, U.-H. (2009). Nexin-1 inhibits the activity of human brain trypsin. Neuroscience 160, 97–102.10.1016/j.neuroscience.2009.02.042Suche in Google Scholar

Koivunen, E., Huhtala, M.L., and Stenman, U.H. (1989). Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J. Biol. Chem. 264, 14095–14099.10.1016/S0021-9258(18)71648-7Suche in Google Scholar

Koumandou, V.L. and Scorilas, A. (2013). Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One 8, e68074.10.1371/journal.pone.0068074Suche in Google Scholar PubMed PubMed Central

Kryza, T., Silva, M.L., Loessner, D., Heuzé-Vourc’h, N., and Clements, J.A. (2016). The kallikrein-related peptidase family: dysregulation and functions during cancer progression. Biochimie 122, 283–299.10.1016/j.biochi.2015.09.002Suche in Google Scholar PubMed

Liu, Y., Kati, W., Chen, C.M., Tripathi, R., Molla, A., and Kohlbrenner, W. (1999). Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal. Biochem. 267, 331–335.10.1006/abio.1998.3014Suche in Google Scholar PubMed

Lopez-Otin, C. and Bond, J.S. (2008). Proteases: multifunctional enzymes in life and disease. J. Biol. Chem. 283, 30433–30437.10.1074/jbc.R800035200Suche in Google Scholar PubMed PubMed Central

Miyai, M., Matsumoto, Y., Yamanishi, H., Yamamoto-Tanaka, M., Tsuboi, R., and Hibino, T. (2014). Keratinocyte-specific mesotrypsin contributes to the desquamation process via kallikrein activation and LEKTI degradation. J. Invest. Dermatol. 134, 1665–1674.10.1038/jid.2014.3Suche in Google Scholar PubMed

Nyberg, P., Ylipalosaari, M., Sorsa, T., and Salo, T. (2006). Trypsins and their role in carcinoma growth. Exp. Cell. Res. 312, 1219–1228.10.1016/j.yexcr.2005.12.024Suche in Google Scholar PubMed

Oiva, J., Itkonen, O., Koistinen, R., Hotakainen, K., Zhang, W.M., Kemppainen, E., Puolakkainen, P., Kylänpää, L., Stenman, U.H., and Koistinen, H. (2011). Specific immunoassay reveals increased serum trypsinogen 3 in acute pancreatitis. Clin. Chem. 57, 1506–1513.10.1373/clinchem.2011.167965Suche in Google Scholar PubMed

Paju, A. and Stenman, U.H. (2006). Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor. Crit. Rev. Clin. Lab. Sci. 43, 103–142.10.1080/10408360500523852Suche in Google Scholar PubMed

Quesada, V., Ordóñez, G.R., Sánchez, L.M., Puente, X.S., and López-Otín, C. (2009). The Degradome database: mammalian proteases and diseases of proteolysis. Nucleic Acids Res. 37 (Database issue), D239–D243.10.1093/nar/gkn570Suche in Google Scholar PubMed PubMed Central

Ramachandran, R., Altier, C., Oikonomopoulou, K., and Hollenberg, M.D. (2016). Proteinases, their extracellular targets, and inflammatory signaling. Pharmacol. Rev. 68, 1110–1142.10.1124/pr.115.010991Suche in Google Scholar PubMed

Rawlings, N.D., Barrett, A.J., and Bateman, A. (2012). MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 40, D343–D350.10.1093/nar/gkr987Suche in Google Scholar

Rinderknecht, H., Renner, I.G., Abramson, S.B., and Carmack, C. (1984). Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86, 681–692.10.1016/S0016-5085(84)80117-1Suche in Google Scholar

Sahin-Toth, M. (2005). Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. Protein Pept. Lett. 12, 457–464.10.2174/0929866054395356Suche in Google Scholar PubMed PubMed Central

Salameh, M.A. and Radisky, E.S. (2013). Biochemical and structural insights into mesotrypsin: an unusual human trypsin. Int. J. Biochem. Mol. Biol. 4, 129–139.Suche in Google Scholar

Salameh, M.A., Soares, A.S., Hockla, A., Radisky, D.C., and Radisky, E.S. (2011). The P(2)′ residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity. Biochem. J. 440, 95–105.10.1042/BJ20110788Suche in Google Scholar PubMed PubMed Central

Salameh, M.A., Soares, A.S., Alloy, A., and Radisky, E.S. (2012). Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors. Protein Sci. 21, 1103–1112.10.1002/pro.2097Suche in Google Scholar PubMed PubMed Central

Schilling, O. and Overall, C.M. (2008). Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26, 685–694.10.1038/nbt1408Suche in Google Scholar PubMed

Schmidt, A.E., Sun, M.F., Ogawa, T., Bajaj, S.P., and Gailani, D. (2008). Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and β-branching on the catalytic activity of blood coagulation factor XIa. Biochemistry 47, 1326–1335.10.1021/bi701594jSuche in Google Scholar PubMed PubMed Central

Shaw, J.L. and Diamandis, E.P. (2007). Distribution of 15 human kallikreins in tissues and biological fluids. Clin. Chem. 53, 1423–1432.10.1373/clinchem.2007.088104Suche in Google Scholar PubMed

Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., et al. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Systems Biol. 7, 539.10.1038/msb.2011.75Suche in Google Scholar PubMed PubMed Central

Szabó, A., Salameh, M.A., Ludwig, M., Radisky, E.S., and Sahin-Tóth, M. (2014). Tyrosine sulfation of human trypsin steers S2′ subsite selectivity towards basic amino acids. PLoS One 9, e102063.10.1371/journal.pone.0102063Suche in Google Scholar PubMed PubMed Central

Szepessy, E. and Sahin-Tóth, M. (2006). Human mesotrypsin exhibits restricted S1′ subsite specificity with a strong preference for small polar side chains. FEBS J. 273, 2942–2954.10.1111/j.1742-4658.2006.05305.xSuche in Google Scholar PubMed PubMed Central

Szmola, R., Kukor, Z., and Sahin-Tóth, M. (2003). Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J. Biol. Chem. 278, 48580–48589.10.1074/jbc.M310301200Suche in Google Scholar PubMed PubMed Central

Takahashi, S., Irie, A., Katayama, Y., Ito, K., and Miyake, Y. (1987). Activation mechanism of human urinary prokallikrein using trypsin as a model activator. Biochem. Int. 14, 467–474.Suche in Google Scholar

Takayama, T.K., Fujikawa, K., and Davie, E.W. (1997). Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein. J. Biol. Chem. 272, 21582–21588.10.1074/jbc.272.34.21582Suche in Google Scholar PubMed

Uehara, S., Honjyo, K., Furukawa, S., Hirayama, A., and Sakamoto, W. (1989). Role of the kallikrein-kinin system in human pancreatitis. Adv. Exp. Med. Biol. 247B, 643–648.10.1007/978-1-4615-9546-5_106Suche in Google Scholar PubMed

Valiev, M., Bylaska, E.J., Govind, N., Kowalski, K., Straatsma, T.P., Van Dam, H.J.J., Wang, D., Nieplocha, J., Apra, E., Windus, T.L., et al. (2010). NWChem: a comprehensive and scalable open-source solution for large scale molecular simulations. Comput. Phys. Commun 181, 1477–1489.10.1016/j.cpc.2010.04.018Suche in Google Scholar

Vilen, S.T., Suojanen, J., Salas, F., Risteli, J., Ylipalosaari, M., Itkonen, O., Koistinen, H., Baumann, M., Stenman, U.H., Sorsa, T., et al. (2012). Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP. Cancer Invest. 30, 583–592.10.3109/07357907.2012.716467Suche in Google Scholar PubMed

Wang, Y., Luo, W., and Reiser, G. (2008). Trypsin and trypsin-like proteases in the brain: proteolysis and cellular functions. Cell. Mol. Life Sci. 65, 237–252.10.1007/s00018-007-7288-3Suche in Google Scholar PubMed

Wu, P., Weisell, J., Pakkala, M., Peräkylä, M., Zhu, L., Koistinen, R., Koivunen, E., Stenman, U.-H., Närvänen, A., and Koistinen, H. (2010). Identification of novel peptide inhibitors for human trypsins. Biol. Chem. 391, 283–293.10.1515/bc.2010.030Suche in Google Scholar PubMed

Yamamoto-Tanaka, M., Motoyama, A., Miyai, M., Matsunaga, Y., Matsuda, J., Tsuboi, R., and Hibino, T. (2014). Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation. J. Biol. Chem. 289, 20026–20038.10.1074/jbc.M113.543421Suche in Google Scholar PubMed PubMed Central

Yoon, H., Laxmikanthan, G., Lee, J., Blaber, S.I., Rodriguez, A., Kogot, J.M., Scarisbrick, I.A., and Blaber, M. (2007). Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282, 31852–31864.10.1074/jbc.M705190200Suche in Google Scholar PubMed

Yoon, H., Blaber, S.I., Evans, D.M., Trim, J., Juliano, M.A., Scarisbrick, I.A., and Blaber, M. (2008). Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis. Protein Sci. 17, 1998–2007.10.1110/ps.036715.108Suche in Google Scholar PubMed PubMed Central

Yoon, H., Blaber, S.I., Debela, M., Goettig, P., Scarisbrick, I.A., and Blaber, M. (2009). A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15. Biol. Chem. 390, 373–377.10.1515/BC.2009.026Suche in Google Scholar PubMed PubMed Central

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22, 184–204.10.1210/edrv.22.2.0424Suche in Google Scholar PubMed